Sjögren's Foundation

Sjögren's Foundation Committed to Conquering and Improving Lives through Education, Support, Advocacy, Research Let's treat everyone with respect.
(795)

Sjögren’s (“SHOW-grins”) is a systemic autoimmune disease that affects the entire body. Along with symptoms of extensive dryness, other serious complications include profound fatigue, chronic pain, major organ involvement, neuropathies, and lymphomas. As a systemic disease, affecting the entire body, symptoms may remain steady or worsen overtime. There is no one single progression of the disease and this can make it challenging for patients and their physicians. While some people experience mild discomfort, others suffer debilitating symptoms that greatly impair their functioning. Early diagnosis and proper treatments are important as they may prevent serious complications and greatly improve a patient's quality of life. About half of the time Sjögren's occurs alone, and the other half it occurs in the presence of another autoimmune connective tissue disease such as Rheumatoid Arthritis, Lupus, or Scleroderma. In addition, Sjögren's is often misrepresented as a rare disease, however it is estimated that there are four million Americans living with this disease, making it one of the most prevalent autoimmune diseases. The Sjögren’s Foundation is proud to be the first and only national non-profit health organization leading the charge to conquer Sjögren’s. While focused on increasing research, education and awareness for this disease, the Foundation works on behalf of all Sjögren’s patients and is dedicated to conquering the complexities of this life-altering and debilitating disease. The Foundation is committed to supporting all Sjögren’s patients while acknowledging the truly complex nature of this disease. Our initiatives, programs and overall efforts are first and foremost started, advanced and expanded, with the Sjögren's patient in mind. With so many people living with questions about their disease and concerned about their disease progressing, we want to make a difference for patients and provide them with answers as well as a sense of hope, now, and for the future. The Foundation brings the voice of patients to the highest levels – to the halls of Congress, primary agencies of the United States Government, leading medical centers and prominent research institutions. We help patients tell their stories to put a human face on Sjögren's, and address the misunderstanding of this complex disease. The Foundation also serves as the lead organization for Sjögren’s worldwide. The Foundation reserves the right to remove without notice any comments, accounts, photos, videos or graphics that are unlawful, obscene, spam or otherwise offensive. This includes but is not limited to advertising or spam, vulgar or disturbing language or images, posts that may violate the rights of others, are disrespectful to any community member, go against the Facebook Statement of Rights and Responsibilities and Community Standards, or any other Facebook term or policy. Community members that repeatedly violate these guidelines will be blocked. Additionally:
Be Kind and Courteous
We're all in this together to create a welcoming environment. Healthy debates are natural, but kindness is required. No Hate Speech or Bullying
Make sure everyone feels safe. Bullying of any kind isn't allowed, and degrading comments about things like race, religion, culture, sexual orientation, gender or identity will not be tolerated. No Promotions or Spam
Give more than you take to this community. Self-promotion, spam and irrelevant links aren't allowed. Respect Everyone's Privacy
Being part of this community requires mutual trust. Authentic, expressive discussions make communities great, but may also be sensitive and private. What's shared in the community should stay in the community.

argenx announced today that it will discontinue its Phase 3 UNITY study evaluating efgartigimod subcutaneous (SC) (efgar...
10/08/2026

argenx announced today that it will discontinue its Phase 3 UNITY study evaluating efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with moderate-to-severe Sjögren's disease.

According to argenx's press release, the decision is based on the recommendation from an Independent Data Monitoring Committee (IDMC) to stop the study for futility following an interim analysis.

argenx reported that safety observed in the study was consistent with the established efgartigimod profile with no new safety signals identified.

Following study close and database lock, argenx will conduct a comprehensive analysis of the data to understand the study outcomes and generate insights that may inform future research in Sjögren's disease.

Read argenx's press release: https://argenx.com/news/2026/press-release-3376934.html

We’re excited to introduce the Sjögren’s Symptom & Impact Tracker, a new resource designed to help you keep track of the...
10/08/2026

We’re excited to introduce the Sjögren’s Symptom & Impact Tracker, a new resource designed to help you keep track of the symptoms, flares, and changes you experience and how Sjögren’s affects your daily life.

Whether you’re preparing for an upcoming appointment or simply trying to make sense of patterns in your symptoms, the tracker gives you a place to capture what you’re experiencing in one convenient, guided experience.

Developed with input from people living with Sjögren’s and healthcare experts, this new tool gives you a consistent way to capture your symptoms, flares, and how Sjögren’s is affecting your everyday life.

Use the tracker to help organize what matters most before your next healthcare visit and feel more prepared to talk with your healthcare provider about what you’re experiencing.

Because what happens between appointments matters, too.

Explore the Sjögren’s Symptom & Impact Tracker and learn how it can help you prepare for your next appointment: https://sjogrens.org/symptomtracker

It’s almost time! The Walk for Sjögren’s is this weekend! Whether you’re walking with family and friends, cheering from ...
10/06/2026

It’s almost time!

The Walk for Sjögren’s is this weekend! Whether you’re walking with family and friends, cheering from the sidelines, or participating from wherever you are, we can’t wait to come together for Sjögren’s.

Get ready to walk, connect, and show your support for the Sjögren’s community!

Let’s make this weekend count, if you haven't registered yet there is still time!
www.walkforsjogrens.org/fall

 : When seeking information on Sjögren’s, consider the source. Make sure the source is authoritative, knowledgeable and ...
10/06/2026

: When seeking information on Sjögren’s, consider the source. Make sure the source is authoritative, knowledgeable and up-to-date.

That’s exactly what you’ll find at Fall Focus: Mind, Body, and Sjögren’s. Hear directly from experts about fatigue, brain fog, sleep, movement, and more, and leave with a better understanding of the symptoms that affect daily life with Sjögren’s.

Register for Fall Focus and get trusted information from experts who understand Sjögren’s: www.sjogrens.org/fallfocus

Could diet affect salivary gland health in people living with Sjögren’s disease?A Sjögren’s Foundation-funded researcher...
10/01/2026

Could diet affect salivary gland health in people living with Sjögren’s disease?

A Sjögren’s Foundation-funded researcher is exploring the potential connection between nutrition and salivary gland health, and what this could mean for people living with Sjögren’s.

This research is part of the Sjögren’s Foundation’s largest annual research investment in our history, with more than $1 million invested in research this year.

In our new Research Spotlight, learn more about this study, what researchers hope to discover, and how this work could help improve our understanding of Sjögren’s disease.

https://sjogrens.org/blog/2026/researcher-spotlight-could-diet-affect-sjogrens-salivary-gland-health

 : Try using a humidifier to help combat nasal & sinus dryness associated with Sjögren’s. For Sjögren’s patients, an opt...
09/29/2026

: Try using a humidifier to help combat nasal & sinus dryness associated with Sjögren’s. For Sjögren’s patients, an optimal range of humidity is between 55% and 60% regardless of the ambient temperature. You can monitor the humidity in your home with a simple humidistat.

We encourage you to share this tip on your page and comment below with your experience(s).

We had a great meeting this week with leadership at the National Institute of Arthritis and Musculoskeletal and Skin Dis...
09/24/2026

We had a great meeting this week with leadership at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to talk about Sjögren's disease and the research gaps that matter most to patients: earlier diagnosis, understanding the varied manifestations of the disease, and why Sjögren's affects people so differently.

This is a hopeful moment for our community. With new therapies on the horizon, the research questions have never been more urgent, and we're grateful to NIAMS for a thoughtful conversation and an openness to continued collaboration. We look forward to working together to close these gaps for the four million Americans living with Sjögren's.

Amgen has announced topline results from its Phase 3 OASIZ 301 clinical trial evaluating investigational dazodalibep in ...
09/23/2026

Amgen has announced topline results from its Phase 3 OASIZ 301 clinical trial evaluating investigational dazodalibep in people with Sjögren’s disease and moderate-to-severe systemic disease activity.

According to Amgen, the study met its primary endpoint, measuring change in systemic disease activity at Week 48. The company plans to present detailed results from the study at an upcoming medical meeting.

The Sjögren’s Foundation welcomes continued progress across the Sjögren’s research landscape and looks forward to learning more as additional data become available.

Read Amgen's press release here: https://www.amgen.com/newsroom/press-releases/2026/09/amgen-announces-positive-topline-phase-3-results-for-dazodalibep-in-moderatetosevere-systemic-sjgrens-disease

 : When dealing with reflux avoid lying flat during sleep. Try elevating the head of your bed by a few inches using bed ...
09/22/2026

: When dealing with reflux avoid lying flat during sleep. Try elevating the head of your bed by a few inches using bed risers or a wedge pillow.

We encourage you to share this tip on your page and comment below with your experience(s).

New research from the Sjögren’s Foundation is now published in Arthritis Care & Research, and it’s an important step tow...
09/22/2026

New research from the Sjögren’s Foundation is now published in Arthritis Care & Research, and it’s an important step toward better understanding how Sjögren’s disease can affect the brain and central nervous system.

It is the first comprehensive review to examine the frequency and range of Central Nervous System (CNS) manifestations reported in people with Sjögren’s disease.

The findings show that people with Sjögren’s can experience a wide range of neurological symptoms and conditions, including brain fog and cognitive difficulties, migraine, insomnia, depression, vision problems, movement disorders, and spinal cord involvement, among others.

The study also found that several of these conditions occur more often in people with Sjögren’s than in the general population. While more research is needed to better understand these connections, greater awareness of CNS involvement may help healthcare providers recognize symptoms and ensure they are appropriately addressed.

Because we want everyone in the Sjögren’s community to have access to this research, the Sjögren’s Foundation purchased open access to the study, allowing patients, families, and healthcare providers to read the full article without a subscription or paywall.

https://acrjournals.onlinelibrary.wiley.com/doi/abs/10.1002/acr.80166?campaign=wolacceptedarticle

Receive updates about treatments, upcoming events, advocacy and more.

Address

10701 Parkridge Boulevard , Suite 170
Reston, VA
20191

Alerts

Be the first to know and let us send you an email when Sjögren's Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Sjögren's Foundation:

Shortcuts

Share